AI and the Future of Vaccine Development—by Wayne Koff

Dr. Wayne Koff is Managing Partner of Next Frontier Advisors, a scientific consulting firm at the nexus of human immunology, vaccine R&D, and AI, that delivers strategic advisory services to optimize and advance R&D for improved global health. Formerly, he was the founding President and CEO of the Human Immunome Project (previously called the Human Vaccines Project), a non-profit R&D consortium focused on decoding the human immune system to accelerate vaccine and therapeutic development.

Dr. Koff has served in senior R&D leadership roles at the International AIDS Vaccine Initiative, United Biomedical Inc., and the NIAID, and established the Neutralizing Antibody Consortium which identified HIV broadly neutralizing antibodies currently in development. Between 2020-2024, he was Adjunct Professor, Dept. of Epidemiology at the Harvard TH Chan School of Public Health and has published over 100 scientific papers and edited eight books on vaccine development. 

Dr. Koff was named in 2019 by Foreign Policy along with Barack and Michelle Obama, Bill and Melinda Gates, Angela Merkel, and others as one of the 100 Global Thinkers who have “had a profound impact on the planet in the last 12 months”.

Language
English

Registration
Deadline: 8 December 2024
Register

Meeting link
The meeting link will be sent to participants after registration.

Scientific organisation
Dr. Klaus Schwamborn
Head of Vaccine Development 
Translational Project Management Office (TPMO) 
Product Development Unit (PDU)
Tel.: +49 151 5272 6147
Send an e-mail

Contact
Dr. Simon Schröder
Translational Project Management Office (TPMO) 
Product Development Unit (PDU)
Tel.: +49 531 6181 1174
Mobile: +49 151 5272 6223
Send an e-mail